Publications

November 7, 2018
Editorial

Congress Should Set the Fed's Inflation Target—Ideally at Zero

By: Amar Bhidé

2020
Working Paper

The Cost of Anonymous Lemons

By: Amar Bhidé

Rules that restrict information required in negotiated private transactions have spurred a vast increase in the scope of anonymous financial markets, particularly in the US. The subtle costs of the information restricting rules raise questions about the social value of... View Details

Keywords: Information Asymmetry; Securities; Securitization; Regulation; Liquidity; Information; Financial Markets; Governing Rules, Regulations, and Reforms; Financial Liquidity

01 Oct 1999
News

New Releases

The Entrepreneurial Venture (Second Edition) by William A. Sahlman, Howard H. Stevenson, Michael J. Roberts, and Amar Bhidé (Harvard Business School Press) At least one million... View Details

2010
Book

A Call for Judgment: Sensible Finance for a Dynamic Economy

By: Amar Bhide

Our prosperity requires the enterprise of innumerable individuals and businesses who exercise their imagination and judgment—and bear responsibility for outcomes. And it is through dialogue and relationships that widespread enterprise is fostered, not merely prices in... View Details

Keywords: Recession; Banking; Banks; Finance; Economics; Macroeconomics; Banks and Banking; Banking Industry; Financial Services Industry

September 22, 1981
Article

Exchange Rates: Floating Does It Better

By: Amar Bhidé and Tino Puri

Article

Central Banking Needs Rethinking

By: Amar Bhidé and Edmund Phelps

Article

What's Still Exceptional About America

By: Amar Bhidé and Carl Schramm

June 21, 2016
Article

Brexiters Are Making a Dangerous Mistake in Their Argument for Leaving the EU

By: Amar Bhidé and Anders Barsk

June 13, 2012
Article

To Save Money-Market Mutual Funds, Scrap Them

By: Amar Bhidé and Christopher Papagianis

October 9, 2014
Article

Clay Christensen's Theories Are Great for Entrepreneurs, but Not Executives

By: Amar Bhidé and Pankaj Ghemawat

December 2020 (Revised May 2021)
Background Note

Tales of Life-changing Innovations: Living Drugs | Note on the Development of CAR-T Therapies (through 2019)

By: Amar Bhidé and Srikant M. Datar

Educators

Article

Phelps's Prize

By: Amar Bhidé and Carl Schramm

01 Jun 2018
News

Disrupting India’s Dental Market

Amar Singh (MBA 1998) traces his curiosity about the Indian dental marketplace to the type of experience that might scare most people away for good. Lured in by the $20 price—roughly equal to Singh’s... View Details

Keywords: Sasha Issenberg

December 2020 (Revised May 2021)
Case

Dame Cicely Saunders and the Modern Hospice Movement: A Brother's View

By: Amar Bhidé and Srikant M. Datar

Educators

Other Article

The Root of All Sovereign-Debt Crises

By: Amar Bhidé and Edmund S. Phelps

March 2021 (Revised April 2021)
Technical Note

Tales of Life-changing Innovations: Too Simple to be Safe? | Note on the Development of Fecal Transplants

By: Amar Bhidé and Srikant M. Datar

Educators

July–September 2007
Article

A Dynamic Theory of China-US Trade: Making Sense of the Imbalances

By: Amar Bhidé and Edmund S. Phelps

2024
Working Paper

Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances

By: Amar Bhidé and Srikant M. Datar

In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details

Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms

SSRN